ADAP
Adaptimmune Therapeutics
ADAP
ADAP
67 hedge funds and large institutions have $416M invested in Adaptimmune Therapeutics in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 6 closing their positions.
Holders
67
Holders Change
+11
Holders Change %
+19.64%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
21
Reduced
14
Closed
6
Calls
$88K
Puts
–
Net Calls
+$88K
Net Calls Change
+$87K